• SENSEX 73,694.89
    448.86 (+0.61%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,380.50 1,356.40(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • PTC Industries
    24,750.00 26,049.95(%)
  • NSE
    1,795.00 1,878.00(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Aeroflex
    579.00 613.50(%)
  • Pidilite Inds.
    1,429.05 1,707.95(%)
  • The Bombay Burmah
    1,176.50 1,108.20(%)
  • Billionbrains
    189.10 112.02(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    932.45 1,177.60(%)
  • Birlasoft Ltd
    351.75 473.75(%)
  • Max Healthcare
    865.95 1,196.50(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Adani Ports
    1,857.35 1,891.80(%)
  • Coromandel Inter
    1,734.65 2,496.10(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • JSW Dulux
    286.50 374.67(%)
  • Acutaas Chemical
    4,000.00 3,977.00(%)
  • Moneyview
    52.44 65.43(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zydus Lifesciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Zydus Group
  • BSE Code : 20883.0
  • ISIN : INE010B01027
1,175.50 3 (0.22%)
  • As on 29 Oct 2026 (EOD)
  • Today’s Low

    1,155.90
  • Today’s High

    1,184.30
  • Open

    1,167.00
  • Perv Close

    1,172.90
  • 52W Low

    835.50
  • 52W High

    1,232.10

Key Indicators

  • P/E(TTM)

    32.07

  • Mar.Cap (₹Cr.)

    117,256.58

  • Div & Yield %

    0.09

  • Book Value(₹)

    237.30

  • Debt-Equity Ratio

    0.22

  • AGM Date

    28-Oct-2026

  • EPS

    36.54

  • P/E Ratio

    32.07

Financials Ratios

  • Debt-Equity Ratio

    0.05

  • Mar.Cap (₹Cr.)

    117,256.58

  • RONW (%)

    20.64

  • ROCE (%)

    23.94

Score Board

  • Equity (₹ in Cr.)

    99.75

  • BV (₹)

    237.30

  • Sales( ₹ in Cr.)

    11,486.40

  • NP (in Cr.)

    3,691.18

  • NP Var(%)

    -36.0

  • Div%

    100.0

  • CPS (₹)

    42.60

  • EPS (₹)

    37.00

  • Traded Value (₹ in Lakhs)

    116,907.45

  • 52 Week High

    1,232.10

  • 52 Week Low

    835.50

  • Price BSE

    1172.0

  • Price NSE

    1,176.00

  • Market Capital( in Cr.)

    116,907.45

  • P/C Ratio

    27.50

  • P/E Ratio

    31.70

  • Price Vs.BV

    37.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 11,486.40 15,117.80 10,817.70 8,732.60 7,835.00 7,780.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 11,486.40 15,117.80 10,817.70 8,732.60 7,835.00 7,780.00
Other Income 1,667.50 696.20 1,084.80 548.40 178.70 89.30
Stock Adjustments 151.60 121.10 131.70 -105.10 46.90 148.30
Total Income 13,305.50 15,935.10 12,034.20 9,175.90 8,060.60 8,017.60
EXPENDITURE :            
Raw Materials 3,728.40 3,138.00 3,284.60 3,066.20 2,917.10 2,499.70
Power and Fuel Cost 305.60 286.20 298.20 278.60 245.20 193.20
Employee Cost 1,966.20 1,762.20 1,507.50 1,321.90 1,204.90 1,147.30
Other Manufacturing Expenses 486.70 439.70 347.20 332.50 381.10 363.40
Selling and Administration Expenses 1,805.40 1,629.30 1,016.80 1,040.80 956.50 1,009.10
Miscellaneous Expenses -412.80 247.20 445.00 336.90 578.30 594.40
Employee Benefit Expenses 1,966.20 1,762.20 1,507.50 1,321.90 1,204.90 1,147.30
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,879.50 7,502.60 6,899.30 6,376.90 6,283.10 5,807.10
Operating Profit 5,426.00 8,432.50 5,134.90 2,799.00 1,777.50 2,210.50
Interest 482.90 463.90 390.70 278.20 134.90 70.90
Gross Profit 4,943.10 7,968.60 4,744.20 2,520.80 1,642.60 2,139.60
Depreciation 561.20 523.90 504.40 488.60 478.70 451.10
Profit Before Tax 4,381.90 7,444.70 4,239.80 2,032.20 1,163.90 1,688.50
Current Tax 899.80 1,582.50 934.30 461.80 260.20 303.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -77.70 87.30 -136.00 41.20 45.80 -91.00
Reported Net Profit 3,559.80 5,774.90 3,441.50 1,529.20 857.90 1,476.20
Extraordinary Items -131.38 42.40 6.10 -92.27 -237.64 -156.95
Adjusted Net Profit 3,691.18 5,732.50 3,435.40 1,621.47 1,095.54 1,633.15
Adjustment below Net Profit -10.10 -26.40 -54.00 1.80 -6.90 -15.30
P & L Balance brought forward 18,794.20 13,347.60 10,567.40 9,289.40 8,796.90 7,336.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1,106.90 301.90 607.30 253.00 358.50 0.00
P & L Balance carried down 21,237.00 18,794.20 13,347.60 10,567.40 9,289.40 8,796.90
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 1,100.00 300.00 600.00 250.00 350.00
Dividend Per Share(Rs) 1.00 11.00 3.00 6.00 2.50 3.50
Earnings Per Share-Unit Curr 35.39 57.40 34.21 15.11 8.38 14.42
Earnings Per Share(Adj)-Unit Curr 35.39 57.40 34.21 15.11 8.38 14.42
Book Value 235.31 210.64 156.23 134.78 129.30 124.46
Book Value(Adj)-Unit Curr 235.31 210.64 156.23 134.78 129.30 124.46

Shareholding Pattern

  • Promoter Group

    75.01%

  • Public Share Holding

    24.99%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 42,577 42,577.00 42,577 42,577
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 42,577 0.00 42,577 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 17,581 0.00 17,581 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 235,063 0.02 235,063 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 747,978,452 74.99 747,978,452 2
Others 0 0.00 0 0
Sub Total 748,231,096 75.01 748,231,096 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 17,517 0.00 17,517 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 409,893 0.04 407,583 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 70,274,241 7.05 70,274,241 629
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 41,917,625 4.20 41,917,625 19
Mutual Funds / UTI 68,585,725 6.88 68,585,725 41
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,588,470 0.16 1,588,470 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 182,793,471 18.33 182,791,161 719
2] Non Institution
Bodies Corporate 5,823,637 0.58 5,823,637 1,157
Clearing Members 158,207 0.02 158,207 58
Directors of their Relatives 376,693 0.04 376,693 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,507,793 0.35 3,500,968 10,844
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,431,312 0.14 1,430,562 4,672
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,375,146 0.74 7,375,146 6
Individuals holding nominal share capital up to Rs. 1 lakh 45,488,518 4.56 44,388,623 364,502
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 195,541 0.02 195,541 19
Others 1,668,944 0.17 1,668,944 2
Sub Total 66,436,688 6.66 65,329,218 381,335
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 997,503,832 100.00 996,394,052 382,067

Company Background

Zydus Lifesciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zydus Lifesciences Ltd
  • BSE Code : 20883.0
  • ISIN : INE010B01027
  • Incorporation Year

    1995

  • Registered Office

    Zydus Corporate Park S No 536
    Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad,
    Gujarat-382481

  • Telephone

    91-079-26868100

  • FAX

    91-079-26868337/26862365/26862366

  • Chairman

    Pankaj R Patel

  • Managing Director

    Sharvil P Patel

  • Company Secretary

    Dhaval N Soni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Zydus Lifesciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zydus Lifesci. 1,172.00 13,151.50 11,484.00 33.27 15.90
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77